Cheers for the report Beanpea. Not often Sprott puts out such a positive report, with... assumptions to the upside that are in the near term, not actually proven, at least in regards to producers. The potential 100koz p.a from a 3rd production centre is still a way off, simply because Memot is still very new/early.
I try to transparent, I took quite a bit off the table with EMR on Friday to rotate into another producer. Whilst the team can do no wrong, there are other companies that also have proven themselves, but do not attract any sort of premium like EMR. Bullseye 60% holding is still an impediment.
At $2.25, EMR will have a market cap of around $1.32billion. That is getting close to CMM, which... is of similar caliber, but... it's second project is arguably better than Bullseye at this stage (not just because its 100% owned). Though who knows, perhaps Okvau can get up towards 200k p.a. Then all bets are off!
Perhaps I will soon enough look back at my repositioning as a mistake, but... we will see.
Good luck to all holders.
EMR Price at posting:
$1.93 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)